loadpatents
Patent applications and USPTO patent grants for Ohlmeyer; Michael.The latest application filed is for "dihydropyridines for the treatment of cognitive impairment or traumatic brain injury".
Patent | Date |
---|---|
Dihydropyridines For The Treatment Of Cognitive Impairment Or Traumatic Brain Injury App 20210230117 - Ohlmeyer; Michael ;   et al. | 2021-07-29 |
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents Grant 10,759,790 - Ohlmeyer , et al. Sep | 2020-09-01 |
Compositions and methods for treating cancer Grant 10,744,141 - Goutham , et al. A | 2020-08-18 |
Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols Grant 10,450,282 - Ohlmeyer , et al. Oc | 2019-10-22 |
Cyclic vinylogous amides as bromodomain inhibitors Grant 10,351,511 - Zhou , et al. July 16, 2 | 2019-07-16 |
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents Grant 10,221,158 - Ohlmeyer , et al. | 2019-03-05 |
Heterocyclic Constrained Tricyclic Sulfonamides As Anti-cancer Agents App 20180251444 - OHLMEYER; Michael ;   et al. | 2018-09-06 |
Heterocyclic Constrained Tricyclic Sulfonamides As Anti-cancer Agents App 20180251456 - OHLMEYER; Michael ;   et al. | 2018-09-06 |
Stereospecific Process For 3-heterocyclylcycloaliphatic-1,2-diols App 20180230112 - OHLMEYER; Michael ;   et al. | 2018-08-16 |
Compositions And Methods For Treating Cancer App 20180185382 - Narla; Goutham ;   et al. | 2018-07-05 |
Cyclic Vinylogous Amides As Bromodomain Inhibitors App 20180105485 - ZHOU; Ming-Ming ;   et al. | 2018-04-19 |
Constrained tricyclic sulfonamides Grant 9,937,180 - Ohlmeyer , et al. April 10, 2 | 2018-04-10 |
Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents Grant 9,937,186 - Ohlmeyer , et al. April 10, 2 | 2018-04-10 |
Cyclic vinylogous amides as bromodomain inhibitors Grant 9,884,806 - Zhou , et al. February 6, 2 | 2018-02-06 |
Tricyclic Heterocycles As Anticancer Agents App 20180002339 - OHLMEYER; Michael ;   et al. | 2018-01-04 |
Tricyclic heterocycles as anticancer agents Grant 9,796,717 - Ohlmeyer , et al. October 24, 2 | 2017-10-24 |
Constrained Tricyclic Sulfonamides App 20170015630 - OHLMEYER; Michael ;   et al. | 2017-01-19 |
Sulfonamides Derived From Tricyclyl-2-aminocycloalkanols As Anticancer Agents App 20170015625 - OHLMEYER; Michael ;   et al. | 2017-01-19 |
Tricyclic compounds as anticancer agents Grant 9,540,358 - Ohlmeyer , et al. January 10, 2 | 2017-01-10 |
Method and compositions for treating cancer and related methods Grant 9,494,572 - Narla , et al. November 15, 2 | 2016-11-15 |
Cyclic Vinylogous Amides As Bromodomain Inhibitors App 20160200666 - ZHOU; Ming-Ming ;   et al. | 2016-07-14 |
Tricyclic Heterocycles As Anticancer Agents App 20150376191 - OHLMEYER; Michael ;   et al. | 2015-12-31 |
Method and compositions for treating cancer and related methods Grant 9,134,297 - Narla , et al. September 15, 2 | 2015-09-15 |
Method and Compositions for Treating Cancer and Related Methods App 20150224101 - Narla; Goutham ;   et al. | 2015-08-13 |
Lipoprotein lipase-activating compositions comprising benzene derivates Grant 8,895,599 - Neagu , et al. November 25, 2 | 2014-11-25 |
Tricyclic Compounds As Anticancer Agents App 20140213578 - Ohlmeyer; Michael ;   et al. | 2014-07-31 |
1-(4-ureidobenzoyl)piperazine derivatives Grant 8,759,352 - Cooke , et al. June 24, 2 | 2014-06-24 |
Inhibitors Of Bromodomains As Modulators Of Gene Expression App 20140066410 - Zhou; Ming-Ming ;   et al. | 2014-03-06 |
Lipoprotein Lipase-activating Compositions Comprising Benzene Derivates App 20130296342 - NEAGU; Irina ;   et al. | 2013-11-07 |
Method and Compositions for Treating Cancer and Related Methods App 20120322792 - Narla; Goutham ;   et al. | 2012-12-20 |
N-benzyl,N'-arylcarbonylpiperazine derivatives Grant 8,314,091 - Ho , et al. November 20, 2 | 2012-11-20 |
5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators Grant 8,211,927 - Roughton , et al. July 3, 2 | 2012-07-03 |
1-(4-ureidobenzoyl)piperazine Derivatives App 20120015958 - Cooke; Andrew John ;   et al. | 2012-01-19 |
PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS App 20110218189 - Roughton; Andrew Laird ;   et al. | 2011-09-08 |
Purinones and 1H-imidazopyridinones as PKC-theta inhibitors Grant 7,989,459 - Roughton , et al. August 2, 2 | 2011-08-02 |
8-substituted 2-(benzimidazolyl)purine derivatives for immunosuppression Grant 7,915,268 - Lu , et al. March 29, 2 | 2011-03-29 |
5- Phenyl-isoxazole-3-carboxamide Derivatives As Trpv1 Modulators App 20110065764 - Roughton; Andrew Laird ;   et al. | 2011-03-17 |
Lipoprotein Lipase-activating Compositions Comprising Benzene Derivatives App 20110065728 - Neagu; Irina ;   et al. | 2011-03-17 |
2-(1-oxo-1H-isoquinolin-2-yl)acetamide derivatives Grant 7,906,504 - Letourneau , et al. March 15, 2 | 2011-03-15 |
Purines As Pkc-theta Inhibitors App 20110046131 - Neagu; Irina ;   et al. | 2011-02-24 |
Quinazolinone and isoquinolinone acetamide derivatives Grant 7,820,649 - Letourneau , et al. October 26, 2 | 2010-10-26 |
2-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonists Grant 7,807,686 - Letourneau , et al. October 5, 2 | 2010-10-05 |
N-benzyl,n'-arylcarbonylpiperazine Derivatives App 20090264416 - Ho; Koc-Kan ;   et al. | 2009-10-22 |
2-(4-Oxo-4H-Quinazolin-3-Yl) Acetamides and Their Use as Vasopressin V3 Antagonists App 20080214553 - Letourneau; Jeffrey ;   et al. | 2008-09-04 |
Quinazolinone And Isoquinolinone Acetamide Derivatives App 20080090802 - Letourneau; Jeffrey ;   et al. | 2008-04-17 |
Purinones and 1H-imidazopyridinones as PKC-theta inhibitors App 20080085909 - Roughton; Andrew ;   et al. | 2008-04-10 |
8-substituted 2-(benzimidazolyl)purine Derivatives For Immunosuppression App 20080085898 - Lu; Yingchun ;   et al. | 2008-04-10 |
2-(1-oxo-1h-isoquinolin-2-yl)acetamide Derivatives App 20080064678 - Letourneau; Jeffrey ;   et al. | 2008-03-13 |
Compounds with medicinal effects due to interaction with the glucocorticoid receptor App 20070149577 - Hamilton; Niall Morton ;   et al. | 2007-06-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.